Scientists have discovered a hidden fibrous sheath beneath the belly button that explains why navels stay concave for life.
Dr. Rubin highlights a new subcutaneous induction for UC, stressing convenience, access, and sustained remission.
The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection. The agent (Tecentriq Hybreza, Genentech) is the first subcutaneous anti-PD-L1 cancer immunotherapy approved in the ...
Dr. Eric K. Singhi shares his insights into the advantages of the subcutaneous formulation of Opdivo versus the IV version for patients with solid tumors. In an interview with CURE®, Dr. Eric K.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback